1 1 1.1....................................... 1 1.2................................ 1 1.3 HIV STD......................... 2 1.4.....................



Similar documents
日本でエイズが増え続ける原因は何か

1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) ( 9) ( 8) ( 12)

キヤノンマーケティングジャパングループ CSR報告書 情報セキュリティ報告書


40

(Travel Medicine) (Emerging Re-emerging Diseases) ) ) ) ) ) ) ) 10 ) 12 ) ) 12 ) 13 ) 14 ) 15 ) 17 ) 18 ) 20 ) 22 24

表紙1-4

橡SP01.pdf

00~33.換気マニュアル

16

() 2

*1和-1 共通(HD-ミライト) ホールディングス会社概要

NGO HIV HIV 8, ,378 1,078 1,331 2,409 9,749 2,038 11,787 2, , ,118 2,344 1,352 3, , ,


H1-4_0603no.ai

DocuPrint C5450 ユーザーズガイド



0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2



Microsoft Word - 37.doc

20 NPO NPO NGO

表紙 PDF



まとめ原稿9-1

untitled

untitled

PTA II

1章

大谷女子大学紀要(よこ)49☆/4.横浜

音声読み上げブラウザの読み上げかた


1 2 2

2 $ 0.41 $ 0.06 $ 0.44 $ (0.05) -- (0.05) (0.32) (0.02)

cm H.11.3 P

untitled

Microsoft Word - 教材ガイド一覧ビデオ.doc

No ii

SEX


14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1=

2000年11月21日


FMV-TEOシリーズ(2008年6月版)製品カタログ

ウクライナ・モルドバプロジェクト確認調査報告書(中小企業振興・保健医療分野案件形成)

1

<4D F736F F D C8B89CA816992B882A282BD8EE582C882B288D38CA982C68D CF092CA8FC882CC8D6C82A695FB816A817995CA A>

レジャー産業と顧客満足の課題

環境報告書2015.indd

[ 708 ] , EU 48 OECD OECD

2 27 4,200 1,890 8,400 14, /

untitled




Microsoft Word - 蝗ウ・抵ス橸シ


2014度事業報告書p000_018.indd

???

橡長沼事件関係資料_041002_.PDF

はじめに


飯能市と名栗村の新しいまちづくり計画に関する住民意識調査

大学等における社会人の受け入れ状況調査

untitled


280-NX702J-A0_TX-1138A-A_NX702J.indb

CSR

MM0508-見聞記01.ind

帝国議会の運営と会議録をめぐって

ソーシャル・サポートの尺度を用いた分析の試み


,829 [ 633 ] , EU 48 OECD OECD

地域と文化資産


27.\..

”Лï−wŁfl‰IŠv‚æ89“ƒ(ŠªŠð†E”åŠv‰Æ’Ñ)/‚²‰ÆŸ_Ł¶‚èŒÚ‹êŠŠŁ\

2

2

1

JT_AR14J_p001-p075_0410.indd

2 SPECIAL FEATURE BBTV-CM 20 BB 35

★索引.indb

n..

Canon EOS Kiss Digital N 製品カタログ

h1


01-全体表紙.PDF

24回日本エイズ学会誌1_ indd

FX自己アフリエイトマニュアル

FX ) 2

CM 7 60

01.trtitle.doc


12-特集08.indd

1 (1) (2) 2

46

* ,195,393 1,269,415 $8,987,917 45,664 96, ,338 10,679 50,318 80,293 5,180 25,177 38,947 ** 1,193,011 1,240,008 8,970,008

Transcription:

K111 B 650006 Wang Xu 650031 XU Ying Mao 650026 650027 650028 650063 : 2006 6 12

1 1 1.1....................................... 1 1.2................................ 1 1.3 HIV STD......................... 2 1.4............................ 5 1.5................................ 7 2 9 2.1............................. 9 2.1.1....................... 9 2.1.2.................... 10 2.1.3.......... 12 2.2........................... 13 2.2.1................................. 13 2.2.2.............................. 14 2.2.3............................... 16 2.2.4............................. 17 2.3........................... 18 2.3.1 SSL.................... 18 2.3.2 SSL HealthCare Japan Ltd....................... 21 2.4......................... 22 2.4.1......................... 22 2.4.2.............................. 29 2.4.3............................ 30 2.4.4........................ 31 2.4.5......................... 32 2.4.6.......................... 35 2.4.7..................... 40 3 42 3.1................................. 42 3.2.............................. 49 i

3.3................................. 52 4 54 4.1......................... 54 4.2........................ 54 4.3................................ 56 4.4.............................. 57 4.5..................................... 63 4.6..................................... 66 4.7................. 67 4.8..................................... 68 4.9..................................... 69 4.10....................................... 69 5 70 ii

1 1.1 65 1500 (2006 5 ) 10 [1] 0.03 (30 ) NO.1 EU NO.1 SSL ( ) durex ( 40 [2]) 26 (ISO JIS ) 1 1 1.2 0.02 0.1mm [21] 1

1.3 HIV STD HIV(Human Immunodeficiency Virus) 2006 5 31 1981 1981 6500 (HIV) 2500 (UNAIDS 5 30 3 2 5 1 2005 570 550 [26] HIV/ 1 4 HIV/ HIV 10% 9 48 10 HIV/ 4 1 80 61 47 2005-2010 38 [35] 1. 2001 300 2. 3. 1,300 4. 5. ARV [52] HIV UNAIDS 5 30 2

94 1990 [27] 2005 HIV 75 7 5000 2010 1000 [12] 2005 HIV 65 7.5 0.05% 05 7 2.5 [17] [13] HIV HIV HIV STD HIV 2005 7536 3715 STD HIV HIV STD HIV STD 1826 STD STD 1493 STD STD STD 1.1 3

1.1: HIV [25] 4

HIV HIV HIV HIV [36] HIV STD 1.1 [16] HIV WHO [19] 500 1000 [16] HIV 1.4 [20] STD 5

- - IUD IUD STD HIV STD STD 1 100 IUD 6

1.5 1.2: [5] 1.4 3000 1564 ( ) 1671 14 1844 42 1909 7

1 [21] 3000 1493 STD 8

2 2.1 2.1.1 3 7 4 9 2 1 2 3 4 2.1: 9

2.2 30 2.2: 2 STD 2.1.2 STD 2.1 1 144 2.1 1997 9 8,587,626 / 1 144 2004 16 4,703,813 / 7 3,883,813 / 45.23 1997 9 4,001,709 / 2004 16 / 2,931,042 / 7 1,070,667 / 26.76 1997 9 2,670,140 / 2004 16 1,772,771 / 7 897,369 / 33.61 10

2.1: [25] 11

2.1 1987 62 1997 2004 2.3 ( ) ( ) 6,042,832 672,671 48,547 2,018 2.3: 2.3 STD HIV STD HIV 2.4.1 2.1.3 13,047,630,000 643,000,000 547,436,431 300,000,000 2.4: 2.4 20 2.4 2.2 2.5 12

2.2: 2.5: 2.2 2.2.1 2 1998 30 0.03 30 3 13

2.2.2 OEM 20 0.02 3 20 1998 2 16 44 1969 30 29 30 1 2 20% 40% 20 1998 4 9 5000 20 1 1 14

3 5 3 30 20 Radical innovation Radical innovation 1998 2006 8 30 20 29 30 30 1 3 30 2 1 15

2.2.3 OEM 2004 10 1 10 OEM OEM 1990 6 3 16

2005 2 5 20 002 26 2.2.4 30 HP 2 30 30 30 12 FX 4 2 2 17

Start-Up 20 2 2.3 EU EU SSL 2.3.1 SSL SSL Durex group 51.9 m Company 144.2 m ssl 51.9 m Group 200 51.9 m = 51, 900, 000 m 10 6 = 100 51, 900, 000 200 = 103, 800, 000, 000 (1038 ) 18

130 8 SSL 2.3 SSL 2.4 2.3: SSL 2.4: SSL 150 40 40 26 10 4000 Durex 2.5: Sales Analyzed by Geography [23] 2.6: Sales Analysed by Brand [23] 2.5 2.6 SSL SSL 150 2.5:Sales Analyzed by Geography 8040 1 SSL 2.5 Durex 19

SSL School( ) EU 127,480,000 2002 727,000,000 2002 5.7 2.6:Sales Analyzed by Brand durex 34 3 1 SSL SSL 2 2 20 ( ) 1938 ( ) SSL LRC(London Robber Company) SSL Scholl( ) SSL Durex SSL Scholl( ) 2.6 Scholl SSL Scholl Footcare(20 ) Scholl Footwear(16 ) Durex 32 36 4 Scholl SSL Durex 20

2.3.2 SSL HealthCare Japan Ltd. SSL SSL HealthCare Japan Ltd. 1988 63 7 26 470,000,000 4 7 SSL HealthCare Japan 2.7 SSL HealthCare Japan 2.8 2.7: SSL HealthCare Japan 2.8: SSL HealthCare Japan Dr.scholl,durex,Coppertone SSL SSL Scholl Dr.Scholl( ) Durex Dr.scholl Coppertone UV 21

2.4 2.4.1 STD HIV STD HIV 2005 4 38% 6.2% 18.9% 11.8% 9.8% [28] 6.7% HIV HIV 22

2 HIV 10.2 2004 HIV HIV HIV HIV STD 1 STD HIV 2 HIV 2.10 [41] HIV ( ) 2 4 ARC) 1 10% 23

2.9: Unknown HIV 24

2.10: HIV [40] ARC ( ) 3 STD 3 25

HIV STD HIV 2.6 2001 13.9 12.6 2005 11.7 11.5 2.6: 4 1 2 2.7 2001 18 17.3 2005 18.2 17.2 2.7: 4 1 4 26

2004 2.8 47% 51% 27% 29% 2.8: AV 27

AV STD HIV 2.11 2.12 2.11: 2003 [51] 2.12: [51] 2.11 STD HIV 62% 2.12 10 9 89% HIV STD 28

2.4.2 20 44 1998 29

1. 2. 20 3. 4. 1 2 2 3 2 2 2 3 4 20 EU 2.4.3 2.3: Made in China Made in Japan Made in Japan 2.3: 30

2006 3 2 2 2.4.4 24 31

18 2006 1 1 [29] 24 PC 24 2.4.5 4 32

1. 2. 3. 4. HIV STD SSL International SSL HealthCare Japan Ltd SSL durex SSL SSL SSL 33

SSL STD HIV STD HIV 2 1?? EU SSL HIV/AIDS 2005 [64] 120 65 180 34

HIV STD 2.4.6 1826 18 2005 1 20 2005 1 21 [30] 2 1989 11 35

[31] 13 [32] HIV STD HIV STD 5 150 President s Emergency Plan for AIDS Relief PREFAR HIV/AIDS 36

USAID NGO PEPFAR NGO DKT DKT International HIV/AIDS PEPFAR DKT 2 6 Phil Harvey HIV HIV/AIDS Transactional sex [33] HIV British Medical Journal HIV HIV WHO 42.6 5 37 4 43 37

HIV 4 11 27 The Lancet HIV HIV HIV HIV [34] STD HIV 1 HIV HIV HIV/AIDS 2005 [64] 72 57 89 PITM prove it to me!: 38

epidemic [53] 2.13: x 2.13 x 51 56 6 49 55 39

8 31 2.13 PITM HIV 40 HIV Social Responsibility 2.4.7 STD HIV 40

2001 7.7 10.2 2005 9 10.2 2.9: 2.9 HIV 7.7 9 ISO 2 4 SSL SSL 2 41

3 3.1 9 (1934 42 (1909 1 0.03 1. 2. 3. 4. 5. 6. 50 60 7. 8. 9. 10. 42

11. 12. 18 4 7 (1932 1 1 8 1933 12 43

0.1 1 8 12 9 2 4 11 SSL [54] 44

2 2 45

16 4 20 8 15 20 43 43 0.04 20 23 43 0.03 30 46

20 20 0.04 8 35 0.02 0.03 44 2 003 3 29 1998 20 1 9 47

1 1 1 48

3.2 JIS 1. 2. 10 1 2 3 4 3. (a) (b) (c) (d) (e) (f) 2 49

4. (a) (b) (c) (d) (e) 5. (a) (b) (c) (d) 6. (a) 30 50

(b) (c) (d) 1 7. 8. (a) (b) (c) JIS ISO 51

3.3 3.1 60 10 52

% 33,185 48.6% 34,027 51.4% 66,212 100.0% 3.1: 109 3.1 43 SSL 33% 53

4 4.1 1. 2. 3. 4. 5. 6. 7. 8. 9. 4.2 54

30 / (4320 / ) 2005 3 2 20 55

4.3 1998 20 20 2.4.4 0.02 20 2005 4 5 0.02 1 [37] 56

500cvs fx-cvs1500 am/pm 4.4 4.4 HIV STD HIV STD SSL HIV STD HIV STD 57

HIV STD HIV STD SSL HIV STD HIV STD HIV STD 58

love cosmetic [50] 1 16 [48] 3 27 16 [47] JR FASTECH360 JR FASTECH( )360S JR 59

6 360 JR JR JR [47] 4.1: FASTECH360S [49] 4.2: [47] 17 17 3500 60

[47] 4.3: 17 5 4 1 CD 43 61

2006 6 7 HIV STD STD 62

4.5 HIV STD HIV STD HIV STD 13,047,630,000 2005 1 5% 1.3 6.5 1.3 6.5 CM 63

64

11!! 5!!!?!?!!! [38] 4.4: 65

HIV HIV STD 4.6 3 66

4.7 HIV RNA MazF T- CEM 2 3 [42] m [42] HIV Transgenic plant production of Cyanovirin-N,an HIV microbicode 1983 NA CG NA [43] 67

1996 [44] 1996 3 [45] HIV STD 3 3 1 4 4.8 2004 12 7 IBM PC [46] HIV 68

4.9 HIV 4.10 4 2 HIV STD 2 HIV HIV 69

5 HIV STD HIV HIV HIV STD 2006 70

1 1934 9 2 1969 44 30 3 1998 10 20 4 1. 2. HIV 71

72

[1] http://www.arkot.com/jinkou/ [2] durex http://www.durex.com/jp/index.asp http://www.durex.jp/feeling.html [3] http://www.okamoto-inc.jp/ [4] http://www.sagami-gomu.co.jp/corp/ [5] http://www.fujilatex.co.jp/ [6] http://www.zepharma.com/ [7] SSL International PLC http://www.ssl-international.com/ [8] SSL healthcare Japan ltd http://www.sslhealthcare.jp/ [9] : http://www.matino-akari.com/linksyu/log/news/03410.html [10] http://www.okamoto-condoms.com/factory/factory.html [11] http://www.jfshm.org/topics/condom.html [12] http://abchina.seesaa.net/article/13389498.html 73

[13] http://news.searchina.ne.jp/disp.cgi?y=2004&d=0803&f=national 0803 007.shtml [14] http://www.people.ne.jp/2001/04/10/jp20010410 4497.html [15] http://news.searchina.ne.jp/disp.cgi?y=2004&d=1202&f=national 1202 003.shtml [16] http://news.searchina.ne.jp/topic/174.html [17] http://news.searchina.ne.jp/disp.cgi?y=2006&d=0125&f=national 0125 002.shtml [18] HIV http://www.aids-hiv.jp/menu/data2.html [19] http://ja.wikipedia.org/wiki/%e5%90%8c%e6%80%a7%e6%84%9b%e8%80%85 [20] http://ja.wikipedia.org/wiki/%e5%90%8c%e6%80%a7%e6%84%9b%e8%80%85 [21] http://ja.wikipedia.org/wiki/%e3%82%b3%e3%83%b3%e3%83%89%e3%83%bc %E3%83%A0 [22] http://www.stat.go.jp/data/sekai/02.htm#02-04 [23] SSL International PLC http://www.ssl-international.com/ [24] SSL healthcare Japan ltd http://www.sslhealthcare.jp/ [25] HIV STD http://www.jfshm.org/topics/condom.html [26] http://www.komei.or.jp/ 74

[27] http://nna.asia.ne.jp.edgesuite.net/ [28] YOMIURI ONLINE http://www.yomiuri.co.jp/komachi/news/rensai/20050526sw91.htm [29] http://www.pref.ehime.jp/030kenminkankyou/120kenminkatsudou/00007366051104/pdf27366.pdf [30] HIV/AIDS http://square.umin.ac.jp/cbel/bioethics data/hiv aids.html [31] http://www.cbcj.catholic.jp/jpn/committee/hiv/hiv4.htm [32] http://ja.wikipedia.org/wiki/%e5%a9%9a%e5%89%8d%e4%ba%a4%e6%b8%89 [33] http://blog.livedoor.jp/ajf/archives/cat 50022575.html [34] japan-lifeissues.net http://japan-lifeissues.net/writers/zen/zen 01condomconundrums.html [35] http://nippon.zaidan.info/seikabutsu/1999/00182/contents/008.htm [36] 1000 http://medwave2.nikkeibp.co.jp/wcs/leaf?cid=onair/medwave/tpic/356430 [37] 2005.6.30 http://www.sagami-gomu.co.jp/release/sagami rl 20050630 2.pdf [38] http://skygarden.shogakukan.co.jp/skygarden/owa/solrenew detail?isbn=4091370799 [39] Yoshiaki Tsuzuki,2000, http://homepage2.nifty.com/kazami/baidokuh.html [40] http://www.pref.aichi.jp/kenkotaisaku/aids/ [41] http://www.pref.mie.jp/nhoken/kensa/hiv-2.htm 75

[42] News http://www.takara-bio.co.jp/news/2006/05/15-5.htm [43] 4 http://www.unlimit517.co.jp/ana77.htm [44] THE BUSINESS SUPPORT http://www.immd.co.jp/news/news 19960401.html [45] http://www.immd.co.jp/news/news 19960708.html [46] MYCOM IBM PC 12 5,000 http://journal.mycom.co.jp/news/2004/12/08/103.html [47] 18 3 6 ( ) http://www.sankei.co.jp/enak/2006/mar/kiji/06jrtokaimoe.html [48] http://www.yurikamome.co.jp/outline/voice.php [49] RAILWAY JOURNAL http://www.rail-j.com/topics/050629.html [50] http://www.lc-condom.jp/index.html [51] Durex http://www.durex.com/jp/assets/gss/local sex2003 menu10.htm [52] HIV/ http://www.msf.or.jp/access/disease.php?name=hiv [53] http://ja.wikipedia.org/wiki/%e3%83%91%e3%83%b3%e3%83%87%e3%83%9f%e3 %83%83%E3%82%AF [54] http://www.okamoto-condoms.com/eiko/p12.html 76

[55] Golbal Sex Servey2001 http://www.durex.com/jp/assets/gss/2001 Global report phase 1.pdf [56] Local Sex Servey2003 http://www.durex.com/jp/assets/gss/local sex2003.htm?intmenuopen=10 [57] Golbal Sex Servey2004 http://www.durex.com/jp/gss2004result.pdf [58] Golbal Sex Servey2005 http://www.durex.com/jp/gss2005result.pdf [59] Anthropological reseach at Intel http://blog.outlogic.jp/shiba/archives/001795.html [60] 16 http://www.jaame.or.jp/seisan/h16 36.htm [61] 16 http://www.jaame.or.jp/seisan/h16 37.htm [62] 10 p.25 http://www.meti.go.jp/topic-j/esyh51cj.pdf [63] 2 2-4 (2005) http://www.stat.go.jp/data/sekai/zuhyou/0204.xls [64] HIV/AIDS 2005 http://api-net.jfap.or.jp/siryou/worldnow/2005/11n.pdf 77